Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose Nevirapine

This publication has 9 references indexed in Scilit:

• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy
  New England Journal of Medicine, 2004
• Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
  The Lancet, 2003
• Synonymous–non-synonymous mutation rates between sequences containing ambiguous nucleotides (Syn-SCAN)
  Bioinformatics, 2002
• Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
  AIDS, 2001
• Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
  AIDS, 2000
• Human Immunodeficiency Virus Load in Breast Milk, Mastitis, and Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1
  The Journal of Infectious Diseases, 1999
• A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)
  AIDS, 1999
• Mother-To-Child Transmission Of Human Immunodeficiency Virus Type 1: Report From The Nairobi Study
  The Journal of Infectious Diseases, 1994